Insider Trading - Gemini Therapeutics Inc. (GMTX)

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Gemini Therapeutics Inc.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-08-14
Purchase
2020-10-19
8:49 pm
FS Development Corp. FSDC FS Development Holdings LLC
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Tananbaum James B.
10% Owner
441,500 $10 $4,415,000 441,500
(Direct)
View
2021-05-14
Purchase
2021-05-18
4:45 pm
Gemini Therapeutics Inc. GMTX Piekos Brian
CFO
7,655 $9.462 $72,432 7,655
(Direct)
View
2021-05-14
Purchase
2021-05-18
4:45 pm
Gemini Therapeutics Inc. GMTX Meyenburg Jason Patrick
CEO
13,000 $9.4561 $122,929 13,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-02-05
Option Award
2021-02-09
3:04 pm
N/A
N/A
Gemini Therapeutics Inc. GMTX FS Development Holdings LLC
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
10% Owner
1,500,000 $10 1,500,000
(Direct)
View
2021-02-05
Conversion
2021-02-09
3:04 pm
N/A
N/A
Gemini Therapeutics Inc. GMTX FS Development Holdings LLC
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
10% Owner
2,928,750 $0 2,928,750
(Direct)
View
2021-02-05
Conversion
2021-02-09
3:04 pm
N/A
N/A
Gemini Therapeutics Inc. GMTX FS Development Holdings LLC
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
10% Owner
2,928,750 $0 0
(Direct)
View
2021-02-05
Option Award
2021-02-09
4:00 pm
N/A
N/A
Gemini Therapeutics Inc. GMTX Tananbaum James B.
Director
1,500,000 $10 1,500,000
(Indirect)
View
2021-02-05
Conversion
2021-02-09
4:00 pm
N/A
N/A
Gemini Therapeutics Inc. GMTX Tananbaum James B.
Director
2,928,750 $0 2,928,750
(Indirect)
View
2021-02-05
Conversion
2021-02-09
4:00 pm
N/A
N/A
Gemini Therapeutics Inc. GMTX Tananbaum James B.
Director
2,928,750 $0 0
(Indirect)
View
2021-02-23
Option Award
2021-02-25
4:51 pm
N/A
2031-02-22
Gemini Therapeutics Inc. GMTX Lauder Scott
CTO
272,615 $0 272,615
(Direct)
View
2021-02-23
Option Award
2021-02-25
4:52 pm
N/A
2031-02-22
Gemini Therapeutics Inc. GMTX Redmond Precillia
Chief People Officer
25,489 $0 25,489
(Direct)
View
2021-03-01
Option Award
2021-03-03
6:37 pm
N/A
2031-02-28
Gemini Therapeutics Inc. GMTX Strapps Walter
Chief Scientific Officer
99,133 $0 99,133
(Direct)
View
2021-03-12
Option Award
2021-03-15
4:18 pm
N/A
2031-03-11
Gemini Therapeutics Inc. GMTX Lubner David Charles
Director
25,000 $0 25,000
(Direct)
View
2021-03-12
Option Award
2021-03-15
4:21 pm
N/A
2031-03-11
Gemini Therapeutics Inc. GMTX Ong Tuyen
Director
15,000 $0 15,000
(Direct)
View
2021-02-05
Option Award
2021-04-07
4:02 pm
N/A
2031-02-04
Gemini Therapeutics Inc. GMTX Lauder Scott
CTO
243,996 $0 243,996
(Direct)
View
2021-02-05
Option Award
2021-04-07
4:03 pm
N/A
2031-02-04
Gemini Therapeutics Inc. GMTX Meyenburg Jason Patrick
CEO
1,124,832 $0 1,124,832
(Direct)
View
2021-02-05
Option Award
2021-04-07
4:04 pm
N/A
2031-02-04
Gemini Therapeutics Inc. GMTX Redmond Precillia
Chief People Officer
77,450 $0 77,450
(Direct)
View
2021-02-05
Option Award
2021-04-07
4:06 pm
N/A
2031-02-04
Gemini Therapeutics Inc. GMTX Uknis Marc
Chief Medical Officer
277,117 $0 277,117
(Direct)
View
2021-03-12
Option Award
2021-04-07
4:07 pm
N/A
2031-02-04
Gemini Therapeutics Inc. GMTX Lubner David Charles
Director
58,855 $0 58,855
(Direct)
View
2021-02-05
Option Award
2021-04-07
4:08 pm
N/A
2031-02-04
Gemini Therapeutics Inc. GMTX Ong Tuyen
Director
58,855 $0 58,855
(Direct)
View
2021-02-05
Option Award
2021-04-07
4:08 pm
N/A
2031-02-04
Gemini Therapeutics Inc. GMTX Strapps Walter
Chief Scientific Officer
79,094 $0 79,094
(Direct)
View
2021-04-12
Option Award
2021-04-14
4:03 pm
N/A
2031-04-11
Gemini Therapeutics Inc. GMTX Barone Samuel B.
Chief Medical Officer
255,212 $0 255,212
(Direct)
View
2021-04-12
Option Award
2021-04-14
4:06 pm
N/A
2031-04-11
Gemini Therapeutics Inc. GMTX Piekos Brian
CFO
377,734 $0 377,734
(Direct)
View
2021-04-28
Option Award
2021-05-03
4:02 pm
N/A
2031-04-29
Gemini Therapeutics Inc. GMTX Strapps Walter
Chief Scientific Officer
9,000 $0 9,000
(Direct)
View
2021-04-29
Option Award
2021-05-03
4:02 pm
N/A
2031-04-28
Gemini Therapeutics Inc. GMTX GEMAYEL GEORGES
Director
45,466 $0 45,466
(Direct)
View
2021-10-04
Option Award
2021-10-06
4:15 pm
N/A
2031-10-03
Gemini Therapeutics Inc. GMTX Lubner David Charles
Director
17,245 $0 17,245
(Direct)
View
2021-10-04
Option Award
2021-10-06
4:15 pm
N/A
2031-10-03
Gemini Therapeutics Inc. GMTX Ong Tuyen
Director
17,245 $0 17,245
(Direct)
View
2021-10-04
Option Award
2021-10-06
4:15 pm
N/A
2031-10-03
Gemini Therapeutics Inc. GMTX GORDON CARL L
Director
10% Owner
17,245 $0 17,245
(Direct)
View
2021-10-04
Option Award
2021-10-06
4:15 pm
N/A
2031-10-03
Gemini Therapeutics Inc. GMTX Rhodes Jason P
Director
10% Owner
17,245 $0 17,245
(Direct)
View
2021-10-04
Option Award
2021-10-06
4:15 pm
N/A
2021-10-03
Gemini Therapeutics Inc. GMTX Tananbaum James B.
Director
10% Owner
17,245 $0 17,245
(Direct)
View
2021-10-18
Option Award
2021-10-20
5:49 pm
N/A
N/A
Gemini Therapeutics Inc. GMTX Piekos Brian
CFO
90,720 $0 90,720
(Direct)
View